A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases

A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases

Key Clinical Message When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients....

Full description

Bibliographic Details
Main Authors: Naohiko Nakamura, Shinichi Kinami, Yoritaka Fujii, Seiko Miura, Jun Fujita, Daisuke Kaida, Yasuto Tomita, Takashi Miyata, Hideto Fujita, Nobuhiko Ueda, Takeo Kosaka
Format: Article
Language:English
Published: Wiley 2019-04-01
Series:Clinical Case Reports
Subjects:
capecitabine
gastric cancer
trastuzumab
Online Access:https://doi.org/10.1002/ccr3.2056
id doaj-9d106ec7ebf74fa28f764cb197e6fb62
record_format Article
spelling doaj-9d106ec7ebf74fa28f764cb197e6fb622020-11-25T02:04:36ZengWileyClinical Case Reports2050-09042019-04-017471471810.1002/ccr3.2056A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two casesNaohiko Nakamura0Shinichi Kinami1Yoritaka Fujii2Seiko Miura3Jun Fujita4Daisuke Kaida5Yasuto Tomita6Takashi Miyata7Hideto Fujita8Nobuhiko Ueda9Takeo Kosaka10Department of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanDepartment of Surgical Oncology Kanazawa Medical University Hospital Uchinada, Kahoku JapanKey Clinical Message When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.https://doi.org/10.1002/ccr3.2056capecitabinegastric cancertrastuzumab
collection DOAJ
language English
format Article
sources DOAJ
author Naohiko Nakamura
Shinichi Kinami
Yoritaka Fujii
Seiko Miura
Jun Fujita
Daisuke Kaida
Yasuto Tomita
Takashi Miyata
Hideto Fujita
Nobuhiko Ueda
Takeo Kosaka
spellingShingle Naohiko Nakamura
Shinichi Kinami
Yoritaka Fujii
Seiko Miura
Jun Fujita
Daisuke Kaida
Yasuto Tomita
Takashi Miyata
Hideto Fujita
Nobuhiko Ueda
Takeo Kosaka
A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
Clinical Case Reports
capecitabine
gastric cancer
trastuzumab
author_facet Naohiko Nakamura
Shinichi Kinami
Yoritaka Fujii
Seiko Miura
Jun Fujita
Daisuke Kaida
Yasuto Tomita
Takashi Miyata
Hideto Fujita
Nobuhiko Ueda
Takeo Kosaka
author_sort Naohiko Nakamura
title A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_short A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_full A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_fullStr A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_full_unstemmed A remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: A report of two cases
title_sort remarkable clinical response in advanced gastric cancer treated with trastuzumab plus capecitabine combination chemotherapy: a report of two cases
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2019-04-01
description Key Clinical Message When trastuzumab + capecitabine and cisplatin chemotherapy could not be conducted continuously because of severe adverse reactions to cisplatin, trastuzumab + capecitabine could be an alternative systemic chemotherapy options for metastatic or recurrent gastric cancer patients.
topic capecitabine
gastric cancer
trastuzumab
url https://doi.org/10.1002/ccr3.2056
work_keys_str_mv AT naohikonakamura aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT shinichikinami aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT yoritakafujii aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT seikomiura aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT junfujita aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT daisukekaida aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT yasutotomita aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT takashimiyata aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT hidetofujita aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT nobuhikoueda aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT takeokosaka aremarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT naohikonakamura remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT shinichikinami remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT yoritakafujii remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT seikomiura remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT junfujita remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT daisukekaida remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT yasutotomita remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT takashimiyata remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT hidetofujita remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT nobuhikoueda remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
AT takeokosaka remarkableclinicalresponseinadvancedgastriccancertreatedwithtrastuzumabpluscapecitabinecombinationchemotherapyareportoftwocases
_version_ 1724942211644129280

Similar Items